Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT)

NCT07749911 · clinicaltrials.gov ↗

RECRUITING

Status

20000

Enrollment

OTHER

Sponsor class

Conditions

Malaria
PLASMODIUM FALCIPARUM MALARIA

Interventions

BIOLOGICAL: R21/Matris-M Malaria vaccine

Sponsor

Clinton Health Access Initiative Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]